Phase-appropriate Process
Development with QbD

Our process development services employ a phase-appropriate development approach grounded in Quality by Design. We apply structured biologics process development methodologies to support early and late-stage programs, utilizing design-of-experiment techniques in JMP software and our robust, in-house analytical development capabilities. This ensures precise control and scalability throughout upstream and downstream process development.

Phase-appropriate Process Development with QbD Phase-appropriate Process Development with QbD

Top Productivity & Quality Modulation

Our upstream process development team specializes in advanced media and additive screening to drive optimal cell culture performance. We leverage extensive libraries and fine-tune parameters to enhance productivity and stability, ensuring scalable and efficient biologics process development. This upstream expertise supports robust transitions into downstream process development and aligns with overall biopharma manufacturing goals.

Titer Enhancement Platforms

  • • An intensified cell culture platform that improves productivity by increasing the initial cell density (ICD) of a main culture through N-1 perfusion

Quality Modulation Platforms

  • • A modular glycosylation platform to optimize glycosylation regarding ADCC(Antibody Dependent Cellular Cytotoxicity) and CDC(Complement-Dependent Cytotoxicity) functions through the Design-of-Experiment investigation
  • • A precise charge variant modulation platform achieved through a thorough screening process
    • Optimization of media, additives and process parameters (ICD, pH, shifted temperature, feeding rate)

Refined Expertise and Streamlined Optimization

We apply a robust downstream process development strategy using an extensive resin library to address a wide spectrum of purification needs. Our streamlined and efficient screening approach enhances flexibility and consistency across diverse molecule types. These capabilities support high-yield recovery and critical quality attributes, complementing our broader drug substance manufacturing workflows.

Purity and Yield Improvement Through DoE

Our rigorous procedures have consistently resulted in maintaining or improving both yield and purity based on our project experiences.

Formulation and Drug Product Expertise

With deep expertise in formulation development and drug product development, our DP/Formulation Development Group focuses on optimizing formulations to enhance both product stability and therapeutic efficacy. These capabilities are integrated across programs to ensure consistency from early-stage development through drug product manufacturing.

High Concentration Formulation Platform

Samsung Biologics' high concentration formulation platform is engineered to maximize drug delivery efficiency and ensure product stability, supporting complex modalities and delivery routes.

  • • Stable liquid formulation for 150 mg/mL SC injection
    • Achieved viscosity of less than 7 cP

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION